Press Releases MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
3.94 ^USD	-3.90%		-6.41%	-43.87%

Jun. 12	Transcript : MeiraGTx Holdings plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:40 PM
May. 15	Transcript : MeiraGTx Holdings plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MeiraGTx Reports First Quarter 2024 Financial and Operational Results	May. 09	GL
MeiraGTx : Results of a Phase 1, Open-label, Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction – The AQUAx Study	May. 02	PU
MeiraGTx to Participate in Upcoming Investor Conferences	Apr. 24	GL
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference	Apr. 18	GL
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates	Mar. 14	GL
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	Feb. 13	GL
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	Feb. 13	AQ
Progress In Preventing Blindness	Jan. 26	AQ
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors	Jan. 03	AQ
MeiraGTx sells XLRP gene therapy to Janssen	Dec. 22	AQ
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million	Dec. 21	GL
MeiraGTx to Participate in Upcoming Investor Conferences	Nov. 21	GL
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results	Nov. 14	GL
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results	Nov. 14	AQ
BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions	23-10-31	AQ
MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities	23-10-30	GL
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress	23-10-24	GL
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress	23-10-24	AQ
Janssen to Highlight Latest Advances in Retina Portfolio at the European Society of Retina Specialists 2023 Annual Meeting	23-10-04	AQ
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results	23-08-10	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Press Releases

Filters